| Programmable nanoparticle functionalization for in vivo targeting. | |
| | |
MedLine Citation:
|
PMID: 23047896 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The emerging demand for programmable functionalization of existing base nanocarriers necessitates development of an efficient approach for cargo loading that avoids nanoparticle redesign for each individual application. Herein, we demonstrate in vivo a postformulation strategy for lipidic nanocarrier functionalization with the use of a linker peptide, which rapidly and stably integrates cargos into lipidic membranes of nanocarriers after simple mixing through a self-assembling process. We exemplified this strategy by generating a VCAM-1-targeted perfluorocarbon nanoparticle for in vivo targeting in atherosclerosis (ApoE-deficient) and breast cancer (STAT-1-deficient) models. In the atherosclerotic model, a 4.1-fold augmentation in binding to affected aortas was observed for targeted vs. nontargeted nanoparticles (P<0.0298). Likewise, in the breast cancer model, a 4.9-fold increase in the nanoparticle signal from tumor vasculature was observed for targeted vs. nontargeted nanoparticles (P<0.0216). In each case, the nanoparticle was registered with fluorine ((19)F) magnetic resonance spectroscopy of the nanoparticle perfluorocarbon core, yielding a quantitative estimate of the number of tissue-bound nanoparticles. Because other common nanocarriers with lipid coatings (e.g., liposomes, micelles, etc.) can employ this strategy, this peptide linker postformulation approach is applicable to more than half of the available nanosystems currently in clinical trials or clinical uses. |
| | |
Authors:
|
Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N Marsh; Kirk Hou; Michael J Scott; John S Allen; Grace Hu; Susana San Roman; Gregory M Lanza; Robert D Schreiber; Paul H Schlesinger; Samuel A Wickline |
Related Documents
:
|
8001996 - Peak component latency-corrected average method for evoked potential waveform estimation. 10761136 - Automatic generation of knowledge base from infrared spectral database for substructure... 16325436 - Quantifying in vivo mr spectra with circles. 1467336 - Improving data acquisition parameters of 31p in vivo spectra for signal analysis in the... 17644176 - A new approach to the rationale discovery of polymeric biomaterials. 19937606 - Our favorite materials: silica hydride stationary phases. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2012-10-09 |
Journal Detail:
|
Title: FASEB journal : official publication of the Federation of American Societies for Experimental Biology Volume: 27 ISSN: 1530-6860 ISO Abbreviation: FASEB J. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-01-03 Completed Date: 2013-03-07 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 8804484 Medline TA: FASEB J Country: United States |
Other Details:
|
Languages: eng Pagination: 255-64 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63108, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Breast Neoplasms / metabolism, pathology Circular Dichroism Disease Models, Animal Humans Mice Nanoparticles* Spectrometry, Fluorescence Vascular Cell Adhesion Molecule-1 / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
CA-119342/CA/NCI NIH HHS; HL-073646/HL/NHLBI NIH HHS; R01 AR056223/AR/NIAMS NIH HHS; R01 CA043059/CA/NCI NIH HHS; R01 HL073646/HL/NHLBI NIH HHS; U54 CA119342/CA/NCI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Vascular Cell Adhesion Molecule-1 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Next Document: S-nitrosated ?-1-acid glycoprotein kills drug-resistant bacteria and aids survival in sepsis.